These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant. Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina. Saez MS; Aguirre MA; Pérez de Arenaza D; Sorroche P; Nucifora E; Posadas Martinez ML Mol Genet Genomic Med; 2021 Nov; 9(11):e1812. PubMed ID: 34668655 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286 [TBL] [Abstract][Full Text] [Related]
9. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder]. Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in transthyretin amyloidosis therapy. Ueda M; Ando Y Transl Neurodegener; 2014; 3():19. PubMed ID: 25228988 [TBL] [Abstract][Full Text] [Related]
12. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Coelho T; Maurer MS; Suhr OB Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944 [TBL] [Abstract][Full Text] [Related]
13. A rare variant of transthyretin-related amyloidosis associated with exclusive cardiomyopathy in a Hong Kong Chinese patient. Wong CW; Ng WY; So KL; Chan YH; Yip SF; Mak CM J Cardiol Cases; 2018 Dec; 18(6):185-188. PubMed ID: 30595768 [TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547 [TBL] [Abstract][Full Text] [Related]
15. Transthyretin: Its function and amyloid formation. Ueda M Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869 [TBL] [Abstract][Full Text] [Related]
16. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G). Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244 [TBL] [Abstract][Full Text] [Related]
17. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
18. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant. Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314 [TBL] [Abstract][Full Text] [Related]
19. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan. Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687 [TBL] [Abstract][Full Text] [Related]
20. Poor Yield of Routine Transthyretin Screening in Patients with Idiopathic Neuropathy. Namiranian D; Chalk C; Massie R Can J Neurol Sci; 2020 Nov; 47(6):816-819. PubMed ID: 32493526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]